Energy Dome Inks a Strategic Commercial Agreement with Google

 In an industry first, Energy Dome and Google partner to achieve carbon-free energy at scale, deploying commercially proven CO2 Battery long-duration energy storage technology

(BUSINESS WIRE)--Energy Dome, a pioneering company setting the benchmark for long-duration energy storage, has announced a global commercial partnership with Google using Energy Dome’s CO2 Battery technology to enable carbon-free energy for the grids that power Google’s operations. Alongside the commercial agreement, Google has made a strategic investment in Energy Dome.

Why Energy Dome and Google are partnering

Electricity is key to modern life and prosperity. This is increasingly relevant as the energy system is electrified, and economic growth drives new electricity demand, including from computational needs of artificial intelligence and data centers.

Solar and wind are amongst the most cost-effective and rapid ways of delivering capacity to the grid, but are inflexible due to their inherent intermittency. Long-duration energy storage resolves this flexibility constraint by storing solar and wind energy and dispatching it later when needed. For energy users such as Google, this technology enables “firm” electricity to meet demand in a reliable, clean, and cost-effective way.

Google’s first commercial long-duration energy storage deal is part of a growing portfolio of advanced energy technologies needed to realize its ambition to run its operations on 24/7 carbon-free energy by 2030. The selection of Energy Dome’s proven and market-ready CO2 Battery technology reflects its ability to be deployed at the scale, speed and affordability required on a global basis.

The CO2 Battery is capable of continuously dispatching energy for periods of 8 to 24 hours, unlocking enough firm electricity to meet both the baseload and flexibility requirements of large energy users. The modular, site-independent product design uses off-the-shelf equipment without supply chain bottlenecks, ensuring a highly scalable solution to store massive amounts of energy efficiently and cost-effectively.

Furthermore, the mechanical components of the technology help stabilize the grid by providing natural inertia from rotating machinery. This is especially important given the concurrent ramp-up of solar and wind (which lack inertia) with the ramp-down of legacy fossil-fuel power stations, whose inertia is lost when the plants are decommissioned. The CO2 Battery thus contributes to maintaining grid resiliency by acting as a shock absorber to smooth out sudden changes in frequency.

"Google is committed to powering our operations with clean energy, and Energy Dome's technologically proven and scalable long-duration energy storage solution can help us unlock rapid progress,” said Maud Texier, Director of EMEA Energy at Google. “But this isn’t just about Google. By helping to scale this first-of-a-kind LDES technology, we hope to help communities everywhere gain greater access to reliable, affordable electricity and support grid resilience as we integrate more renewable energy sources.”

The commercial agreement aims to develop CO2 Battery projects in all the key geographical strategic areas, including Europe, America, and the Asia-Pacific region, with the goal of scaling up deployment at a rapid pace to meet Google’s 2030 carbon-free energy goals. A pipeline of sites and projects has been identified in the partnership, which are currently in development and contracting stages.

“The programmatic and strategic deployment of our technology at scale to help Google reach carbon-free energy represents the core of our industry-first agreement. We’re proving that a 24/7 cost-effective and carbon-free energy supply is achievable with the right technology and partnership model,” said Claudio Spadacini, Founder and CEO of Energy Dome. “We are also pleased to welcome Google as an investor in Energy Dome, underlining our joint commitment to a shared vision.”

Investment Alongside Commercial Alliance

Beyond the commercial collaboration, Google has also made an investment in Energy Dome. The investment coincides with the company entering a growth phase of commercial deployment, and multiple projects already contracted, including with Alliant Energy in the U.S., Engie in Italy, and NTPC in India.

By investing directly in the Milan-based scaleup, Google is reinforcing its long-term commitment to accelerating the commercialization of this proven technology. As a pioneer in the first generation of corporate power purchase agreements when solar and wind were in their infancy, Google brings both the customer perspective and experience to enhance the maturation and commercial scaling of CO2 Battery technology, unlocking adoption benefits for communities and economies.

About Energy Dome

Energy Dome is at the forefront of redefining long-duration energy storage with its CO2 Battery. The properties of carbon dioxide allow the system to store energy efficiently and cost-effectively through a patented thermo-mechanical process, hence representing the most valid alternative to lithium-ion batteries or pumped-hydro solutions. The CO2 Battery is already a fully validated and cost-effective system that uses no lithium or rare-earth elements to store electricity, boasting superior round-trip efficiency. With a modular approach and site-independent footprint, CO2 Batteries use readily available, off-the-shelf components from reliable, existing supply chains, providing a scalable pathway to store massive amounts of intermittent renewable energy and accelerate the energy transition; it’s the only technology available today offering the right combination of efficiency, cost, scalability and that’s viable globally. For more information, please visit energydome.com.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250724389814/en/

Permalink

https://www.aetoswire.com/en/news/2507202548102

Contacts

Media Contact: Mario Torchio – m.torchio@energydome.com

LEO Pharma Announces FDA Approval of ANZUPGO® (delgocitinib) Cream in the U.S.

 BALLERUP, Denmark -

ANZUPGO® (delgocitinib) cream now becomes the first and only FDA-approved treatment specifically approved for the treatment of adults living with moderate-to-severe chronic hand eczema (CHE) in the U.S.1

CHE affects approximately one in ten adults worldwide, yet previously, there has been no specific treatment FDA-approved for those living with the disease.2,3

The approval represents an important milestone for LEO Pharma’s expanding presence in the U.S. as it broadens its portfolio of dermatology treatments to address unmet needs.

 

(BUSINESS WIRE)--LEO Pharma, a global leader in medical dermatology, announced today that the U.S. Food and Drug Administration (FDA) has approved ANZUPGO® (delgocitinib) cream (20 mg/g) for the topical treatment of moderate-to-severe chronic hand eczema (CHE) in adults who have had an inadequate response to, or for whom topical corticosteroids are not advisable.1

ANZUPGO is an innovative steroid-free, topical pan-Janus kinase (JAK) inhibitor for adults with CHE.1 ANZUPGO inhibits the JAK-STAT pathway, specifically blocking the activity of JAK1, JAK2, JAK3, and tyrosine kinase 2 (TYK2), and suppresses the various inflammatory responses that play a key role in the onset and subsequent flares of CHE.1,2,4

The FDA approval of ANZUPGO marks a significant milestone in LEO Pharma’s strategy to expand its presence in the U.S. market and deliver purposeful innovation in skin health. In preparation for bringing ANZUPGO to the U.S. patients, LEO Pharma has significantly upscaled its operations across key functions – including a 50% increase in the sales force.

“ANZUPGO is a good example of how we transform a real need in the market into medicines that can help make a difference for people living with serious skin diseases such as CHE,” said Christophe Bourdon, CEO, LEO Pharma. “After successfully launching ANZUPGO in several countries, we’re proud to now bring this innovation to adult patients with moderate-to-severe CHE in the United States. The approval of ANZUPGO reinforces our commitment to investing in difficult-to-treat skin conditions to deliver new treatments to patients where the need is greatest. We’re truly grateful to the patients and physicians who participated in our studies and helped make this approval possible.”

CHE is a highly debilitating inflammatory skin disease that affects approximately one in ten adults worldwide, causing itchy, painful, blistered, or swollen skin that can interfere with daily activities.2,3,5,6 The FDA approval of ANZUPGO provides adults in the U.S. living with moderate-to-severe CHE with the first and only treatment option specifically approved for this skin disease, just as it will be the first and only topical pan-JAK-inhibitor on the U.S. market.

“Chronic hand eczema can be a very difficult disease for adults to manage, especially given the lack of treatment options in the U.S. until now,” said Robert Spurr, EVP and President, North America, LEO Pharma. “As the first and only FDA-approved treatment specifically for CHE in the U.S., ANZUPGO further establishes our company's real commitment to bringing treatments to market that address unmet needs in medical dermatology.”

The FDA approval is the latest regulatory milestone for ANZUPGO, following the European Commission (EC) approval in 2024 and several launches internationally, including Germany, Switzerland, the United Kingdom and the United Arab Emirates.

*Ends*

About ANZUPGO® (delgocitinib) Cream

ANZUPGO® (delgocitinib) cream is currently FDA approved in the U.S. as the first and only treatment for chronic hand eczema (CHE). ANZUPGO is also approved in the European Union, United Kingdom, Switzerland and the United Arab Emirates for the treatment of moderate-to-severe chronic hand eczema (CHE) in adults for whom topical corticosteroids are inadequate or not advisable. ANZUPGO cream is also under investigation in other markets. Use of ANZUPGO in combination with other JAK inhibitors or potent immunosuppressants is not recommended by the U.S. FDA.1

ANZUPGO cream is a topical pan-Janus kinase (JAK) inhibitor for the treatment of moderate-to-severe CHE in adults. It inhibits the activation of JAK-STAT signaling, which plays a key role in the pathogenesis of CHE.7

In 2014, LEO Pharma A/S and Japan Tobacco Inc. (JT) entered into a license agreement in which LEO Pharma gained exclusive rights to develop and commercialize delgocitinib for topical use in dermatological indications worldwide, excluding Japan, where JT retains rights.

The full U.S. FDA Prescribing Information and Medication Guide are available here: https://www.leo-pharma.us/AnzupgoPI

About Chronic Hand Eczema

Chronic hand eczema (CHE) is defined as hand eczema (HE) that lasts for three or more months or relapses twice or more within a year.5,8 HE is one of the most common skin disorders of the hands and in a substantial number of patients, it can develop into a chronic condition.9 CHE affects approximately one in ten adults worldwide.2,3 It is a fluctuating disorder characterized by itch and pain, and patients may experience signs such as erythema, scaling, lichenification, hyperkeratosis, vesicles, edema, and fissures on hands and wrists.6 The pathophysiology is characterized by skin barrier dysfunction, inflammation of the skin, and alterations of the skin microbiome.2

CHE has been shown to cause psychological and functional burdens that impact patient quality of life,10,11 with approximately 70% of individuals who live with severe CHE admitting to problems in performing everyday activities.12 Furthermore, careers and earning potential have also been shown to be impacted by the burden of living with CHE.13

About LEO Pharma

LEO Pharma is a global leader in medical dermatology. We deliver innovative solutions for skin health, building on a century of experience with breakthrough medicines in healthcare. We are committed to making a fundamental difference in people’s lives, and our broad portfolio of treatments serves close to 100 million patients in over 70 countries annually. Headquartered in Denmark, LEO Pharma has a team of 4,000 people worldwide. LEO Pharma is co-owned by majority shareholder the LEO Foundation and, since 2021, Nordic Capital. For more information, visit www.leo-pharma.com.

References

ANZUPGO® (delgocitinib) cream. Prescribing Information. FDA. July 2025.

Lee GR, Maarouf M, Hendricks AK, Lee DE, Shi VY. Current and emerging therapies for hand eczema. Dermatol Ther. 2019;32(3):e12840.

Quaade AS, Simonsen AB, Halling A-S, Thyssen JP, Johansen JD. Prevalence, incidence, and severity of hand eczema in the general population – A systematic review and meta-analysis. Contact Dermatitis. 2021;84:361–374.

Tanimoto A, Ogawa Y, Oki C, Kimoto Y, Nozawa K, Amano W, Noji S, Shiozaki M, Matsuo A, Shinozaki Y, Matsushita M. Pharmacological properties of JTE-052: a novel potent JAK inhibitor that suppresses various inflammatory responses in vitro and in vivo. Inflamm Res. 2015;64:41-51.

Lynde C, Guenther L, Diepgen TL, et al. Canadian hand dermatitis management guidelines. J Cutan Med Surg. 2010;14(6):267-284. Erratum in: J Cutan Med Surg. 2011 Nov-Dec;15(6):360.

Thyssen JP, Schuttelaar MLA, Alfonso JH, et al. Guidelines for diagnosis, prevention, and treatment of hand eczema. Contact Dermatitis. 2022;86(5):357-378.

Dubin C, Del Duca E, Guttman-Yassky E. Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges. Ther Clin Risk Manag. 2020;16:1319-1332. Erratum in: Ther Clin Risk Manag. 2021 Mar 18;17:233.

Diepgen TL, Andersen KE, Chosidow O, et al. Guidelines for diagnosis, prevention and treatment of hand eczema. J Dtsch Dermatol Ges. 2015;13(1):e1-e22.

Bissonnette R, Diepgen TL, Elsner P, et al. Redefining treatment options in chronic hand eczema (CHE). J Eur Acad Dermatol Venereol. 2010;24 Suppl 3:1-20.

Grant L, Seiding Larsen L, Burrows K, et al. Development of a Conceptual Model of Chronic Hand Eczema (CHE) Based on Qualitative Interviews with Patients and Expert Dermatologists. Adv Ther. 2020;37(2):692-706.

Dalgard FJ, Gieler U, Tomas-Aragones L, et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. 2015;135(4):984-991.

Cortesi PA, Scalone L, Belisari A, et al. Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids. Contact Dermatitis. 2014;70(3):158-168.

Voorberg AN, Loman L, Schuttelaar MLA. Prevalence and Severity of Hand Eczema in the Dutch General Population: A Cross-sectional, Questionnaire Study within the Lifelines Cohort Study. Acta Derm Venereol. 2022;102:adv00626.

MAT-84121 July 2025

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250723974453/en/

Permalink

https://www.aetoswire.com/en/news/54295609

Contacts

 

Jes Frederiksen

Global Corporate Communication

+45 53 60 59 48

jebfe@leo-pharma.com

Jeppe Ilkjær

Global Corporate Communications

+45 30 50 20 14

JEILK@leo-pharma.com

Multiply Group Completes Acquisition of Tendam, Doubling Operational EBITDA and Expanding Global Footprint

ABU DHABI, United Arab Emirates; MADRID, Spain; LONDON, UK; LUXEMBOURG CITY, Luxembourg; and PARIS, France - Wednesday, 23. July 2025


    Tendam is Spain's second-largest apparel group by market share and one of Europe’s leading omnichannel apparel groups.
    Tendam’s 12 well-established owned fashion brands offer diversity and international exposure, further deepening the Group’s presence in consumer-focused industries.
    The transaction, valued at AED 5.6 billion (€ 1.3 billion) enterprise value, positions Multiply Group as a key player in the global Retail & Apparel landscape.

 

Multiply Group (ADX: MULTIPLY), the Abu Dhabi-based investment holding company that invests in and operates businesses globally, today completed its first major investment in Europe with the acquisition of a majority stake in Tendam, Spain’s second-largest apparel group by market share[1]. The deal doubles Multiply’s operational EBITDA post-consolidation and expands its model to acquire standout businesses, unlock potential through capital and tech, and deliver sustained market leadership.

 

As one of Europe’s leading omnichannel apparel groups, Tendam operates more than 1,800 points of sale and runs successful digital loyalty programmes in over 80 markets, including Spain, Portugal, France, the UAE, and Latin America, making it well-positioned in the evolving retail landscape. From affordable fashion to premium styles, the company’s diversified portfolio of 12 established brands caters to multiple customer segments through its leading fashion brands such as Women’secret, Springfield, Cortefiel and Pedro del Hierro, among others.

 

Multiply now has a majority interest of 67.91% in Castellano Investments S.À R.L. (“Company”) (the owner of Tendam Brands S.A.U. and other subsidiaries), with Llano Holdings S.À R.L. and Arcadian Investments S.À R.L., the corporate investment vehicles for CVC Funds and PAI Partners, remaining as minority shareholders.

 

With this investment, Multiply Group deepens its investments in consumer-focused industries and establishes a presence in the retail and apparel sector, with Tendam becoming a platform business under Multiply’s Retail & Apparel vertical.

 

Multiply will lead the next growth phase of Tendam. This growth is predicated on further international expansion across Europe, Latin America, and the Middle East. Embedding AI across all aspects of the business, from sourcing to customer operations, will support this growth journey and will leverage the digital infrastructure the company already has in place. In addition, Multiply will support the business on targeted M&A to introduce new brands and categories.

 

Samia Bouazza, Group CEO and Managing Director of Multiply Group, said: “This acquisition marks Multiply Group’s strategic entry into the retail and apparel sector. By securing a controlling interest in a leading omnichannel platform, we are investing in a future-focused, high-performing business model backed by an outstanding management team. Built on strong, well-established owned brands, the platform offers the agility and vision to expand into new categories and scale emerging brands globally. With our expertise in creating synergies, deploying AI, and driving strategic M&A, we are poised to accelerate growth and unlock long-term value for our shareholders.”

 

From a strategic standpoint, the acquisition offers Multiply Group a significant opportunity to leverage Tendam’s strong brand platform and proven performance to drive future growth, supported by favourable consumer tailwinds in the global apparel retail market.

 

Jaume Miquel, Chairman and CEO of Tendam, highlighted: “Today we are starting a new era. Together, shareholders and management team, will fully deploy the Tendam potential, extending our brands to new formats, markets and channels supported by advanced artificial intelligence and digital technology, delivering stronger growth and profitability through a unique, unrivalled omnichannel brand ecosystem.”

 

Since 2020, driven by its proven management team, Tendam has recorded steady, quarter-on-quarter growth, strengthening its business model in core markets while expanding its international presence. At the end of June 2025, the company reported last twelve months sales of €1.4 billion and EBITDA post-IFRS 16 of €340.7 million.

 

Multiply Group has been advised by Greenhill (a Mizuho affiliate), Hogan Lovells and KPMG on the transaction. Castellano and its current shareholders have been advised by Uria Menendez. Ramón Hermosilla Abogados and Latham & Watkins LLP were legal advisors to Tendam on this transaction.

 

ABOUT MULTIPLY GROUP

 

Multiply Group PJSC is an Abu Dhabi-based investment holding company that globally invests and operates in transformative, cash-generating businesses.

 

Known for its trademark growth mindset, Multiply Group will continue to deploy capital across its two distinct arms, both of which follow a disciplined approach to investing and ensure consistent, sustainable value creation for our shareholders in the short, medium and long term:

 

Multiply, the investments and operations in long-term strategic verticals, currently investing and operating in Mobility, Energy & Utilities, Media & Communications, Wellness & Beauty, and Retail & Apparel. Anchor investments provide long-term recurring income, through which bolt-on acquisitions are made.

 

Multiply+, the Group further engages in opportunistic, sector-agnostic investments, via mainly minority stakes in private and public markets.

 

For more information, visit www.multiply.ae.

 

About Tendam

Tendam is a leading European multibrand, omnichannel vertical apparel retailer and Spain’s second largest player by market share. It operates in the premium mass-market segment and is built on a fully-integrated, customer-centric, data-driven ecosystem. The Company currently has 12 own brands: Women’secret, Springfield, Cortefiel, Pedro del Hierro, Hoss Intropia, Slowlove, High Spirits, Dash and Stars, OOTO, HI&BYE, Milano, and the children’s clothing line Springfield Kids. Tendam also sells close to 200 curated third-party brands through its multibrand, omnichannel platform.

 

Currently, Tendam operates in more than 80 countries through more than 1,800 points of sale (including directly-operated stores, corners and franchises) and online, with 33 websites for eight of its own brands, six apps, and other third-party websites and marketplaces. Tendam's corporate website is available at www.tendam.es
 

[1] The acquisition of Tendam’s businesses in Bosnia and Herzegovina will not become effective until it is authorised by the relevant competition authority, which is expected to be received shortly.

Permalink
https://www.aetoswire.com/en/news/2307202548067

Contacts

For further information, please contact:

Wassim El Jurdi

Multiply Group

E: wassim@multiply.ae

 

Rawad Khattar

Weber Shandwick

M: +971 56 336 2131

E: rkhattar@webershandwick.com

Mary Kay’s Iconic Pink Cadillac Goes Electric with the All-New OPTIQ

 Next-Gen Career Car Drives Innovation, Sustainability, And Business Opportunity into the Future

 

(BUSINESS WIRE)--Global cosmetics giant, Mary Kay Inc., today announced a major milestone in its legacy of empowerment: the transformation of its beloved pink Cadillac into a fully electric vehicle (EV). The pink Cadillac OPTIQ made its debut during Mary Kay’s annual Seminar, hosted for the first time in the vibrant city of Charlotte, North Carolina.

The Cadillac OPTIQ is a significant step forward in Mary Kay’s commitment to innovation, environmental responsibility, and meeting expectations of the next generation of both Mary Kay independent sales force members and their customers. The transition from internal combustion to electric symbolizes more than just a vehicle upgrade, it marks a recharged vision for the future of the iconic beauty brand.

“For decades, the Mary Kay pink Cadillac has symbolized accomplishment, aspiration, and the power of recognition,” said Ryan Rogers, Chief Executive Officer of Mary Kay. “With the introduction of the all-electric OPTIQ, we’re honoring that iconic legacy while driving into a transformative future—one grounded in our commitment to sustainability and dedication to inspiring and celebrating the achievements of our independent sales force for generations to come.”

“Our relationship with Mary Kay spans decades and is built on shared values of innovation, empowerment, and excellence,” said Ian Hucker, VP GM Envolve. “As the organization takes bold steps into the future with the transition to an electric vehicle, we are proud to stand beside them, supporting a vision that’s not only sustainable but also deeply inspiring. The pink Cadillac OPTIQ is an exciting step forward, bringing together the performance and luxury you expect from Cadillac with meaningful innovation and purpose-driven impact.”

About The Pink Cadillac OPTIQ:

OPTIQ retains the instantly recognizable pink pearl exterior, while introducing a sleek, modernized chassis with cutting-edge features. As part of Mary Kay’s commitment to sustainability, the vehicle showcases the company’s dedication to reducing its carbon footprint while continuing to inspire.

OPTIQ’s exceptional aerodynamic performance enables its EPA-estimated 302-mile driving range1. The revolutionary GM EV Battery Platform and drive units, along with the use of low rolling resistance tires, also play an important role in the impressive range of the vehicle.

A vented rear spoiler, diffusers, and other sculptural elements enhance aerodynamics at the rear of the vehicle without compromising the striking SUV vehicle design.

OPTIQ packages interior spaciousness and luxury into a comfortable suite. Illuminated décor and embellishments add to OPTIQ’s unique interior interpretation of Cadillac luxury, while the suite of in-vehicle technology includes features such as the 19-speaker AKG Audio System and Dolby Atmos, creating an intuitive experience.

Did You Know:

The iconic pink Cadillac was born in 1968 when Mary Kay Ash purchased a Cadillac Coupe De Ville from a Dallas dealership and promptly had it painted to match the pale pink Mary Kay® lip and eye palette. General Motors later named the color Mary Kay Pink Pearl, and the shade is exclusive to Mary Kay.

Mary Kay has been named the #1 Direct Selling Brand of Skin Care and Color Cosmetics in the World2 by Euromonitor International for three consecutive years, in 2023, 2024, and again in 2025.

About Mary Kay

One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty brand in Texas in 1963 with one goal: to enrich women’s lives. That dream has blossomed into a global company with millions of independent sales force members in more than 40 markets. For over 60 years, the Mary Kay opportunity has empowered women to define their own futures through education, mentorship, advocacy, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in preserving our planet for future generations, protecting women impacted by cancer and domestic abuse, and encouraging youth to follow their dreams. Learn more at marykayglobal.com. Find us on Facebook, Instagram, and LinkedIn, or follow us on X.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250724749681/en/

Permalink

https://www.aetoswire.com/en/news/54295563

Contacts

 

Mary Kay Inc. Corporate Communications

marykay.com/newsroom

972.687.5332 or media@mkcorp.com

IFF Introduces ENVIROCAP™, a Breakthrough Scent Delivery Technology for Fabric Care

 

NEW YORK - 

The company’s newest sustainable fragrance innovation is fully ECHA-compliant, biodegradable and vegan-suitable.

 

(BUSINESS WIRE)--IFF (NYSE: IFF), a global leader in flavors, fragrances, and biosciences, has launched ENVIROCAP™ — its newest sustainable scent delivery system designed for the future of fabric care. Developed by IFF’s world-class scientists and fragrance delivery experts, ENVIROCAP™ sets a new standard in innovation: it is fully ECHA-compliant¹, biodegradable² and vegan-suitable³. At the heart of this technology is a proprietary biopolymer that delivers long-lasting fragrance while reducing environmental impact. ENVIROCAP™ not only meets the rising consumer demand for sustainability — it redefines the standard for performance and cost-efficiency.

“The launch of ENVIROCAP™ marks a bold new chapter in fragrance encapsulation,” said Ana Paula Mendonça, president, IFF Scent. “In 2005, IFF revolutionized laundry care with scent bursts that brought joy throughout the day. Now, we’re leveraging our leading nature-based bio innovation capabilities to redefine the power of scent technology in laundry — delivering superior sustainability and performance without compromise. With ENVIROCAP™, we aim to support our customers in innovating and bringing true differentiation through elevated sensory impact and sustainability, while delighting consumers with memorable scent experiences.”

The development of ENVIROCAP™ is rooted in IFF’s deep understanding of the consumer’s laundry care journey — from the moment of purchase to the emotional “moment of truth” when freshly washed clothes are experienced for the first time. Around the world, consumers are increasingly seeking sustainable choices and expect brands to take responsibility for designing products with the environment in mind. ENVIROCAP™ directly answers this call. It delivers an uplifting, long-lasting scent experience that enhances freshness from wash to wear — while aligning with the growing demand for eco-friendly, high-performing and value-driven fabric care solutions.

ENVIROCAP™ also allows perfumers great olfactive freedom to harness the virtually limitless possibilities offered by IFF’s extensive fragrance ingredient portfolio. From sparkling citrus to joyful fruity or sensual floral notes and beyond, ENVIROCAP™ works across all stages of the laundry experience — making joy with scent, one laundry cycle at a time.

Learn more about IFF’s delivery systems and encapsulation technologies here.

(1)

 

Regulation (EU) 2023/2055 of 25 September 2023 amending Annex XVII to EU REACH Regulation (Regulation (EC) No 1907/2006) as regards synthetic polymer microparticles,

(2)

 

According to Biodegradability rules as outlined in the Appendix 15 of the EU Microplastics Restriction,

(3)

 

According to the criteria of the Vegan Society | Certificate available on demand

(4)

 

Mintel, The Future of Fabric Care, 2024

Welcome to IFF

At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook.

©2025 International Flavors & Fragrances Inc. IFF, the IFF Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250724026783/en/

Permalink

https://www.aetoswire.com/en/news/2407202548081

Contacts

Judith Gross

Head of Communications and Branding

IFF Scent

media.request@IFF.com

 

MultiBank.io Collaborates with Fireblocks to Bring $10 Billion RWA Vision to Life.

 DUBAI, United Arab Emirates - Thursday, 24. July 2025 AETOSWire Print 

(BUSINESS WIRE)--MultiBank Group, the world’s largest financial derivatives institution, has announced that its digital asset arm, MultiBank.io, will utilize Fireblocks to power a landmark real estate tokenization platform. Designed to bring $10 billion in real-world assets (RWAs) on-chain, this initiative will open new opportunities for secure, compliant, and accessible investment.

The first phase draws on MultiBank.io’s recent $3 billion partnership with MAG Lifestyle Development, featuring flagship projects such as The Ritz-Carlton Residences and Keturah Reserve. With these assets as the foundation, MultiBank.io is now scaling up to deliver one of the largest global real estate tokenization offerings, targeting a $10 billion vision.

This growth is driven by an alliance between MultiBank Group, Fireblocks, and Mavryk Network. Mavryk provides the blockchain infrastructure for on-chain issuance and DeFi integrations. Fireblocks ensures institutional-grade digital asset custody and tokenization, and MultiBank Group brings regulatory expertise, overseeing compliance and governance, and supporting secondary market liquidity.

Through this collaboration, MultiBank.io will offer fractional access to income-generating properties in a regulated environment, an unprecedented move at this scale. The new platform leverages Fireblocks’ advanced security and tokenization engine to manage the entire lifecycle of digital assets, including secure minting and burning, automated compliance, reliable custody, and streamlined secondary trading. At the blockchain level, Mavryk enables rapid settlement and programmable features such as KYC and jurisdictional checks, ensuring a seamless experience for both institutional and retail investors.

“Tokenizing RWAs at scale demands robust infrastructure, uncompromising security, and strict adherence to industry standards,” said Zak Taher, Founder & CEO of MultiBank.io. “Fireblocks is the custody backbone behind our operations, while Mavryk’s blockchain brings speed and efficiency. Together, we’re opening $10 billion in property investment to a wider audience with full transparency.”

This marketplace will be underpinned by the regulatory expertise and reach of MultiBank Group, which has more than two million clients and over 17 licenses worldwide.

ABOUT MULTIBANK GROUP

MultiBank Group, established in California, USA in 2005, is a global leader in financial derivatives. With over 2 million clients in 100+ countries and a daily trading volume exceeding $35 billion, it offers a broad range of brokerage and asset management services. Renowned for innovative trading solutions, robust regulatory compliance, and exceptional customer service, the Group is regulated by 17+ top-tier financial authorities across five continents. Its award-winning platforms provide up to 500:1 leverage across Forex, Metals, Shares, Commodities, Indices, and Cryptocurrencies. MultiBank Group has received over 80 international awards for trading excellence and regulatory compliance. For more information, visit MultiBank Group’s website.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250724771236/en/

Permalink

https://www.aetoswire.com/en/news/2407202548082

Contacts

mohammad.shakfeh@multibankfx.com

00971585754191

ExaGrid’s Q2 2025 Momentum Press Release

 MARLBOROUGH, Mass. - 

ExaGrid Achieves 18th Consecutive Quarter of Free Cash Flow, EBITDA, and P&L Positive Operations

 

(BUSINESS WIRE)--ExaGrid®, the industry’s only Tiered Backup Storage solution with Retention Time-Lock that includes a non-network-facing tier (creating a tiered air gap), delayed deletes and immutability for ransomware recovery, today announced that it continues to grow and drive Free Cash Flow (FCF) and EBITDA.

The company is having another record bookings and revenue year and was FCF positive, P&L positive, and EBITDA positive for its 18th consecutive quarter. ExaGrid added over 140 new customers in the quarter and the average deal size is increasing. ExaGrid has continued to have over 75% of its new logo customer bookings come from six- and seven-figure purchase orders and in Q2, 80% of the new customers were from six- and seven-figure deals.

ExaGrid now has more than 4,700 active upper mid-market to large enterprise customers that use ExaGrid Tiered Backup Storage to store and protect their data. ExaGrid’s customer retention rate remains very high, creating a strong existing customer repeat business.

ExaGrid supports more than 25 backup applications and utilities including: Veeam, Commvault, NetBackup, HYCU, Oracle RMAN direct, SQL Dumps direct, HYCU, and ExaGrid recently announced support of Rubrik, and that it will add support for Cohesity DataProtect in the first half of 2026.

ExaGrid is a financially strong company generating positive cash each quarter and with zero debt of any kind.

Highlights of Q2 2025:

Added over 140 new customers

18th consecutive quarter of Cash, EBITDA, and P&L positive operations

50% of ExaGrid’s business comes from existing customer re-orders

Over 50% of the business came from outside the US

Adding over 14 more sales regions worldwide

Won six industry awards:

April: Data Breakthrough Awards – Data Backup Solution of the Year

May: Network Computing Awards – Air-gapped Ransomware Recovery Product of the Year

May: Network Computing Awards – Company of the Year

May: Network Computing Awards – Storage Product of the Year

June: Storage Awards – Channel Partner Programme

June: Storage Awards – Storage Company of the Year

“We are pleased that we have achieved 18 consecutive quarters of free cash flow and EBITDA. Revenue and EBITDA continue to grow year over year. We are the largest independent backup storage vendor, and we continue to add support and integration with more backup applications which offers investment protection to our existing customers and provides even more potential for top line growth,” said Bill Andrews, President and CEO of ExaGrid. “We’ve hit well over 4,700 active customer installations worldwide. ExaGrid continues to have an over 70% competitive win rate (74.1% in Q2) replacing primary storage behind the backup application, as well as inline deduplication appliances such as Dell Data Domain and HPE StoreOnce.”

About ExaGrid

ExaGrid provides Tiered Backup Storage with a unique disk-cache Landing Zone, long-term retention repository, scale-out architecture, and comprehensive security features. ExaGrid’s Landing Zone provides for the fastest backups, restores, and instant VM recoveries. The Repository Tier offers the lowest cost for long-term retention. ExaGrid’s scale-out architecture includes full appliances and ensures a fixed-length backup window as data grows, eliminating expensive forklift upgrades and planned product obsolescence. ExaGrid offers the only two-tiered backup storage approach with a non-network-facing tier (tiered air gap), delayed deletes, and immutable objects to recover from ransomware attacks.

ExaGrid has physical sales and pre-sales systems engineers in the following countries: Argentina, Australia, Austria, Benelux, Brazil, Canada, Chile, CIS, Colombia, Czech Republic, France, Germany, Hong Kong, India, Israel, Italy, Japan, Mexico, Nordics, Poland, Portugal, Qatar, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Switzerland, Turkey, United Arab Emirates, United Kingdom, United States, and other regions.

Visit us at exagrid.com or connect with us on LinkedIn. See what our customers have to say about their own ExaGrid experiences and learn why they now spend significantly less time on backup storage in our customer success stories. ExaGrid is proud of our +81 NPS score!

ExaGrid is a registered trademark of ExaGrid Systems, Inc. All other trademarks are the property of their respective holders.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250724425630/en/

Permalink

https://www.aetoswire.com/en/news/54295504

Contacts

 

Media:

Mary Domenichelli

ExaGrid

mdomenichelli@exagrid.com